Legislative record

SB 1848STATE · TennesseeIntroduced

Controlled Substances - As enacted, authorizes additional healthcare providers to directly administer buprenorphine mono or buprenorphine without the use of naloxone; adds that prescribing a buprenorphine product to nursing mother or prescribing an injectable mono product does not restrict certain healthcare providers from prescribing a buprenorphine product for the treatment of opioid use disorder without naloxone. - Amends TCA Title 53, Chapter 11.

Voted 4/24/2026View source

Summary

No summary has been published for this bill yet.

Bill text

The full text of this bill isn't on Heard yet. The official documents are linked below.

Roll-call record

How representatives voted

8 yea·1 nay

Docket history

Action history

  1. 4/24/2026Comp. became Pub. Ch. 753
  2. 3/30/2026Companion House Bill substituted
  3. 3/27/2026Placed on Senate Regular Calendar for 3/30/2026
  4. 3/18/2026Recommended for passage, refer to Senate Calendar Committee
  5. 3/17/2026Action deferred in Senate Health and Welfare Committee to 3/18/2026
  6. 3/17/2026Placed on Senate Health and Welfare Committee calendar for 3/18/2026
  7. 3/11/2026Action deferred in Senate Health and Welfare Committee to 3/18/2026
  8. 3/11/2026Placed on Senate Health and Welfare Committee calendar for 3/17/2026
  9. 3/4/2026Placed on Senate Health and Welfare Committee calendar for 3/11/2026
  10. 2/18/2026Action deferred in Senate Health and Welfare Committee to 3/4/2026